Exploring the Impact of Dementia Prevention Programs Using Robots as Intervention Tools on Community Elderly
Launched by NATIONAL TAIWAN NORMAL UNIVERSITY · May 14, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 65 years or older, Able to communicate in Mandarin or Taiwanese, Able to provide informed consent or have a legal guardian provide consent
- Exclusion Criteria:
- • Diagnosis of severe dementia or advanced neurodegenerative disease, Severe psychiatric disorders (e.g., schizophrenia, bipolar disorder), Unconsciousness or inability to stay awake or focused for the session duration, Inability to comply with study protocol or scheduled sessions
About National Taiwan Normal University
National Taiwan Normal University (NTNU) is a prestigious institution dedicated to advancing education and research across various disciplines, including health sciences. As a clinical trial sponsor, NTNU leverages its academic expertise and innovative methodologies to investigate and develop novel therapeutic interventions. The university fosters collaboration between researchers, healthcare professionals, and industry partners to ensure rigorous study design, ethical standards, and comprehensive data analysis. By prioritizing scientific excellence and community health, NTNU aims to contribute significantly to the advancement of medical knowledge and the improvement of patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, Taipei City, Taiwan
Patients applied
Trial Officials
Jong-Long Guo, PhD
Study Chair
National Taiwan Normal University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported